Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Cipla launches ZEMDRI (Plazomicin) in India, aims to tackle AMR
Plazomicin is a novel anti-microbial with demonstrated activity against multi-drug resistant (MDR) bacteria and clinical efficacy…
Pathways involved in DNA repair and other cellular functions could contribute to the development of…
Identifying new drug targets is critical because many of the Alzheimer’s drugs that have been developed to this point haven’t…
Lupin collaborates with Honeywell, plans for HFO technology in Inhalers
Solstice Air offers an alternative to traditional hydrofluorocarbon (HFC)-based propellants, helping to reduce greenhouse gas…
Barentz acquires Fengli, China, aims to strengthen market presence
The partnership would further enhance the service and commercial capabilities of Barentz in China while enabling Fengli Group to…
Tezepelumab’s trial results strengthen potential for biomarker-driven biologic therapies in COPD:…
GlobalData’s latest analysis reveals that tezepelumab, evaluated in the Phase IIa COURSE trial, achieved a 26 per cent reduction…
Pfizer enters into an exclusive licensing agreement with 3SBio
Under the terms of the agreement, 3SBio will grant Pfizer an exclusive global license to develop, manufacture and commercialise…
Department of Biotechnology, BIRAC host webinar on Biomanufacturing for mRNA Therapeutics
The 14th webinar of the biomanufacturing and biofoundry initiative served as a collaborative forum, bringing together academia,…
Venus Remedies joins United Nations Global Compact
As a UNGC participant, the company will publish an annual CoP to share updates on its sustainability performance and adherence to…
US drug pricing order – Implications for India’s pharma sector
Ravi Shah, Partner, Cyril Amarchand Mangaldas explains that while the policy is designed to cut costs for US patients, its effects…
GSK’s Nucala highlights IL-5 inhibition in reducing COPD exacerbations in eosinophilic patients:…
In both groups, Nucala significantly lowered the rate of exacerbations requiring emergency department (ED) visits or…